Prognostic relevance of immunohistochemically detected lymph node micrometastasis in patients with gastric carcinoma
Open Access
- 23 May 2002
- Vol. 94 (11) , 2867-2873
- https://doi.org/10.1002/cncr.10562
Abstract
BACKGROUND Micrometastases consisting of one to a few cells in lymph nodes resected during gastrectomy are difficult to identify using conventional hematoxylin and eosin (H&E) stains. It has been shown that immunostaining for cytokeratins is effective in detecting lymph node micrometastasis in a variety of human tumors, but only a few previous reports demonstrated its use in the treatment of patients with early and advanced gastric carcinoma, and those reports had conflicting results. METHODS In this study, 3625 regional lymph nodes that were dissected in gastrectomy specimens from 153 patients with early‐stage gastric carcinoma (46 patients) and advanced gastric carcinoma (107 patients) were immunostained with the anticytokeratin cocktail AE1/3 for micrometastasis (median, 23 lymph nodes; range, 8–66 lymph nodes). Micrometastasis (MM) was defined as a single tumor cell or clusters of tumor cells that were missed on conventional examination with H&E stains but were detected by immunostaining with broad‐spectrum anticytokeratin antibodies. RESULTS Lymph node metastasis (LNM) was detected in 609 lymph nodes (17%) by H&E staining. MM was identified in another 191 of the remaining lymph nodes (6.3%) from 75 patients. Twenty‐eight of those patients were up‐staged. There was a significant correlation between MM and depth of tumor invasion (P < 0.01). Patients with MM had a decreased 5‐year survival rate (49%) compared with patients without MM (76%) for both early and advanced gastric carcinoma. The effect of MM on survival was most pronounced for patients in the Stage I and LNM negative group. CONCLUSIONS Immunohistochemical examination using broad‐spectrum anticytokeratin antibodies increased the detection rate of LNM and had a significant impact on staging and survival in patients with gastric carcinoma. Cancer 2002;94:2867–73. © 2002 American Cancer Society. DOI 10.1002/cncr.10562Keywords
This publication has 26 references indexed in Scilit:
- Lymph Node Micrometastases in Patients With Early Gastric Cancer: Experience With 139 PatientsAnnals of Surgical Oncology, 2001
- Detection and Prediction of Micrometastasis in the Lymph Nodes of Patients With pN0 Gastric CancerAnnals of Surgical Oncology, 2001
- Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinomaCancer, 1999
- Predictive value of genetic diagnosis for cancer micrometastasisCancer, 1997
- Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrenceSurgery, 1996
- The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinomaThe Journal of Pathology, 1994
- Frequency and Distribution of Occult Micrometastases in Lymph Nodes of Patients With Non-Small-Cell Lung CarcinomaJNCI Journal of the National Cancer Institute, 1993
- Occult regional lymph node metastases from breast carcinoma: Immunohistological detection with antibodies CAM 5.2 and NCRC‐11The Journal of Pathology, 1991
- Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratinsDiseases of the Colon & Rectum, 1991